Business Description
Dr Sulaiman Al Habib Medical Services Group
ISIN : SA1510P1UMH1
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.51 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 2.03 | |||||
Interest Coverage | 30.09 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.62 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.5 | |||||
3-Year EBITDA Growth Rate | 19.5 | |||||
3-Year EPS without NRI Growth Rate | 24.7 | |||||
3-Year Book Growth Rate | 9.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 19.17 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.61 | |||||
9-Day RSI | 58.02 | |||||
14-Day RSI | 55.41 | |||||
6-1 Month Momentum % | 38.07 | |||||
12-1 Month Momentum % | 12.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.79 | |||||
Days Inventory | 31.81 | |||||
Days Sales Outstanding | 32.06 | |||||
Days Payable | 67.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.34 | |||||
Dividend Payout Ratio | 0.7 | |||||
3-Year Dividend Growth Rate | 39.8 | |||||
Forward Dividend Yield % | 1.43 | |||||
5-Year Yield-on-Cost % | 1.37 | |||||
Shareholder Yield % | 0.38 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.39 | |||||
Operating Margin % | 22.19 | |||||
Net Margin % | 21.52 | |||||
FCF Margin % | -2.66 | |||||
ROE % | 32.99 | |||||
ROA % | 14.37 | |||||
ROIC % | 17.57 | |||||
ROC (Joel Greenblatt) % | 23.77 | |||||
ROCE % | 19.77 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 54.02 | |||||
PE Ratio without NRI | 54.02 | |||||
PS Ratio | 11.63 | |||||
PB Ratio | 17.05 | |||||
Price-to-Tangible-Book | 17.37 | |||||
Price-to-Operating-Cash-Flow | 34.09 | |||||
EV-to-EBIT | 51.43 | |||||
EV-to-EBITDA | 45.12 | |||||
EV-to-Revenue | 12.11 | |||||
EV-to-Forward-Revenue | 9.24 | |||||
EV-to-FCF | -446.08 | |||||
Price-to-Graham-Number | 6.52 | |||||
Earnings Yield (Greenblatt) % | 1.95 | |||||
FCF Yield % | -0.23 |